Resources

Type of publications
Regions
Diseases
4046 results found
2012 ∙ Hyde, T. B. Dentz, H. Wang, S. A. Burchett, H. E. Mounier-Jack, S. Mantel, C. F. Gindler, J. Goldstein, S. T. Gordon, W. S. Brenzel, L. Shearer, J. C. Favin, M.
The impact of new vaccine introduction on immunization and health systems: A review of the published literature
All age groups Healthcare workers Hepatitis A Hepatitis B Haemophilus influenzae type B Human papillomavirus (HPV) Japanese encephalitis Meningococcal disease Streptococcus group B Rotavirus Typhoid Cholera Coverage
Methodological quality (AMSTAR 2):
Not applicable
2012 ∙ Quadri-Sheriff, M. Hendrix, K. S. Downs, S. M. Sturm, L. A. Zimet, G. D. Finnell, S. M. E.
The role of herd immunity in parents' decision to vaccinate children: A systematic review
Parents/caregivers Children Adolescents Acceptance Coverage
Methodological quality (AMSTAR 2):
Not applicable
2012 ∙ Thomas, R. E. Lorenzetti, D. L. Spragins, W. Jackson, D. Williamson, T.
The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: Systematic review
Newborn Children Pregnant women Adults Older adults Yellow fever Safety Administration
Methodological quality (AMSTAR 2):
Critically low
2012 ∙ Garcini, L. M. Galvan, T. Barnack-Tavlaris, J. L.
The study of human papillomavirus (HPV) vaccine uptake from a parental perspective: A systematic review of observational studies in the United States
Americas United States of America Adolescents Adults Parents/caregivers Human papillomavirus (HPV) Coverage Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2012 ∙ Demicheli, V. Rivetti, A. Debalini, M. G. Di Pietrantonj, C.
Vaccines for measles, mumps and rubella in children
Newborn Children Adolescents Mumps Measles Rubella Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
High
2012 ∙ Jefferson, T. Rivetti, A. Di Pietrantonj, C. Demicheli, V. Ferroni, E.
Vaccines for preventing influenza in healthy children
Newborn Children Adolescents Influenza Efficacy/effectiveness Safety
Methodological quality (AMSTAR 2):
High
2012 ∙ SAGE
Hepatitis A vaccine and post-exposure prophylaxis
GRADE table Hepatitis A
Download:
2012 ∙ SAGE
Efficacy and safety of hepatitis A vaccines
GRADE table Hepatitis A
Download:
2012 ∙ SAGE
Population impact of Hepatitis A immunization programs
GRADE table Hepatitis A
Download:
2012 ∙ SAGE
Hepatitis A vaccines and long-term protection
GRADE table Hepatitis A
Download:
Loading...